Ultrapar Participacoes SA
BOVESPA:UGPA3
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
18.02
31.08
|
Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Good morning, ladies and gentlemen. At this time, I would like to welcome everyone to Ultrapar’s 2Q ‘20 Results Conference Call. There is also a simultaneous webcast that may be accessed through Ultrapar’s website at ri.ultra.com.br and MZiQ platform. Please feel free to flip through the slides during the conference call.
Today with us, we have Mr. Frederico Curado, Chief Executive Officer; and Mr. André Pires, Chief Financial and Investor Relations Officer; together with the other executives of Ultrapar. We would like to inform you that this event is being recorded. [Operator Instructions] A replay of this call will be available for 1 week.
Before proceeding, let me mention that forward-looking statements are being made under the safe harbor and Securities Litigation Reform Act of 1996. Forward-looking statements are based on the beliefs and assumptions of Ultrapar management and on information currently available to the company. They involve risks, uncertainties and assumptions because they relate to future events, and therefore, depend on circumstances that may or may not occur in the future. Investors should understand that general economic conditions, industry conditions and other operating factors could also affect the future results of Ultrapar and could cause results to differ materially from those expressed in such forward-looking statements.
Now, I’ll turn the conference over to Mr. Curado. Mr. Curado, you may begin the conference.
Thank you and welcome everyone to our quarterly call. This quarter, of course, we felt the direct impact of the COVID-19 pandemic. But in retrospect, we believe that our ability to manage our operations during this crisis is quite efficient. And we were actually able to go through this three challenging months better than we expected. So now since the end of March, we established two priorities, first being the safety of our people and the second being the continuity of our operations. Let’s keep in mind that all of our five businesses were considered essential to the population. And we have an obligation to keep our customers and our consumers properly served regardless of the challenges.
So as far as our people, we have had about 500 confirmed cases so far, which is about – equivalent to about 3% of our team. Of those 500 cases about 450 have already recovered and returned to work. The remaining around 50, they are fulfilling the quarantine. But thanks, god, nobody – actually everybody’s at home. Nobody is even in the hospitals. So if we consider most of our staffs was in the field, I clearly can say, that our protocols for symptom identification for testing, selective isolation and monitoring this protocol, they have been very efficient. Of course, also we have staffs in home office. We began to return to offices last Monday, actually on the August of 3, Monday of last week. And this return is gradual. It’s very smooth, and it’s going on quite well so far.
I believe that the vast majority of companies have realized we certainly have ourselves. The home office has been working extraordinarily well, far beyond what – yes, one might expect before the crisis. So you don’t know where or how what will be the new normal of office work, how do we look like in the future. But surely, we don’t think we will have 100% of our people driving back and forth every day to office. We think this is – there will be some changes to that. And the experience of the next months, several months, I think, will tell us where we’re going to land as far as balancing in our home office and after presence in the office. So it’s been a very interesting learning in this whole period.
Now with regard to the second priority, which is operational continuity, we actually managed to maintain all of our operations without any interruption whatsoever, despite the logistical mobility challenges that we experienced in Brazil in São Paulo in particular, [indiscernible] but we didn’t have a single day of interruption, which is great. So it’s no small thing, yes. I think we have to recognize the quality and the capacity of our teams, also our leaders they will have gone the extra mile in the spirit of ownership and they kept our people save and engage with our commitments.
Now before talking about the results, let me just touch on two other points about the crisis, one, support for our resellers and through the social actions and support to the fight against pandemic. So in short, we keep a very proactive attitude in agile, and we are flexible with our suppliers, with our customers, with our partners, with our resellers. In an attempt to preserve integrity, not only of our operations but of their operations as well and ultimately keep the services to the population. So we were proactive in renegotiating contractual obligations that we were proactive in working in some capital relief measures. So our partners in the end, we did ensure the continuity of the value chain or value chains, but also the stability of the level of the deferrals in our balance sheet, which did not go in the quarter. So that’s another important result.
And one last word on the price of – regarding social support. So we’re talking about reduction about R$200 million – sorry, R$20 million to mainly to the construction of the hospitals always in partnership with private hospital operations and then compared with our current results as well as the change in real in Porto Alegre, for example. We also donated LPG delivered medical equipment, meals for trip drivers. We granted huge discounts for the health professionals among several other actions.
Okay. So let’s move now to the financial results. The impact of the credit was concentrated in Ipiranga, as you probably read in our release, and that, of course, that impacted as a result of the combined effort – combined effect of one significant reduction in demand, mainly gasoline and ethanol and to the sharp decline in oil pricing, of course, we generated a huge amount in inventory value, which, of course will recover over time.
So the other businesses, on the other hand, they showed a normal resilience to the crisis including Extrafarma, which went through the quarter with about 70% of its stores are closed, stores which were located – which are located in shopping malls, which were shutdown. So commenting briefly on the other businesses, Ultrapar had a very good quarter. We did experience some reduction in volume for the bulk customers. These are small and medium sized enterprise. But we saw growth in the household consumption. And we were able to sustain good margins in both segments, bulk and householded. Shipping to Ultracargo, also a good quarter there, despite a small reduction in movement of cargo, but the storage commitments remain very firm, and the margins also remained firm. So it was a good quarter for Ultracargo.
And finally, on September, we had some reduction in volumes for some segments, such as coatings, paintings, oil and gas, obviously, and automotive. But on the other hand, the agri business and the HPC sector that exceeded our expectations. In addition to that, Oxiteno has benefited from the value exchange rates, weaker as we are and also to drop the cost of equity in the next quarter. So in short, we have a good second quarter, for sure. But that tested the resilience of our – and the agility of our trend in our portfolio with results that we deem very satisfactory given the uncertainties and the volatility that we all experienced. So anticipate the second half to continued recovery in the community activity in Brazil and of course, Ipiranga alone. So we believe – we really believe that the greatest equities are behind us already.
So we hope in the next several months is also important. The implementation of the abastece aí, our new business announced a few weeks ago. That business, we believe they will create value, and we really hope to materialize that in coming years. So that’s the start-up phase of this new business. A word on our strategic agenda is our strategic vision, they remain unchanged. On one hand, of course, we continue to pursue improvements in results in all of our businesses. On the other hand, also a lot of discipline, focus on cash management and also, of course, in capital reallocation. All could not have to mention that all of that has to be supported by continued development of a pipeline of talent and also what we call [indiscernible]
Let me make one last comment before giving the floor to André. We – I mean, we could not advance dividends in this semester, but the company maintains – absolutely maintained its commitment to pay the main dividend equivalent of 50% of our annual net income, which, by the way, is income by our bylaws. So we sit not to make this half year advance has been our practice over the years, it will be the context of cash preservation, in context of an economic scenario, which is still uncertain and volatile. So obviously, as usual, the dividend proposal related to the 2020 fiscal year. This will get approval, along with the financial statements for next year in our AGM. So no change there. The only change that we did not advance different at this stage.
So with that, over to you, André. Thank you.
Thank you, Fred, and good morning, everyone. Starting now with Ultragaz on Slide number 5. Sales volume at Ultragaz in the second quarter of 2020 increased by 3% on a year-on-year basis, in line with the market. In the bottled segment, volume grew by 8%, influenced by stronger residential demand for LPG, reflecting the restrictions in place due to the pandemic. On the other hand, bulk sales volume fell by 9% with lower sales to industry, commerce and services, also impacted by the pandemic. This reduction was offset by a growth in sales to condominium and for special gases.
SG&A fell by 11% versus the second quarter of 2019, thanks to steps taken to control expenses with lower expenditures on payroll, business travel and events. In contrast, there was an increase in freight expenses due to higher volume and additional expenditures with donations and for protective equipment in order to tackle the pandemic.
As a result, Ultragaz EBITDA reached R$206 million, a 69% growth compared to the same quarter of last year, due to the increase in sales volume, improved operational efficiency and focus on cost and expenses control. Looking ahead at Ultragaz business environment, we expect to see a gradual recovering sales volume for the bulk segment, mainly coming from industry commercial and services and continued robust performance in the bottled segment. With that, the trend is to maintain solid and consistent results going forward.
Moving on to Slide number 6, talking about Ultracargo. Ultracargo added 19% with average capacity compared to second quarter last year, due to the expansion at Santos and Itaqui terminals implemented over the past 12 months. The cubic meter sold increased by 16% mainly due to the greater handling of fuels and expanded capacity, in addition to the increased in spot operations in Aratu. Ultracargo reported R$155 million of net revenues in the quarter, 23% above the second quarter of 2019 driven by higher average tariffs, new customers, and a large number of spot operations.
Regarding costs and SG&A, we had our combine increased of 4% due to higher payroll expenditures as a consequence of the capacity expansion at Santos and Itaqui terminals and additional expenses were donations and EPIs related to COVID-19. It is important to highlight that Ultracargo reduced its OpEx per cubic meters sold by 10% demonstrating and improved productivity.
In the second quarter of 2020, Ultracargo’s results benefited from tax credits of R$12 million, while in the same quarter of last year, we had a negative impact of R$53 million in connection with the settlement related to the foreign incident in 2015. Ultracargo’s EBITDA reached R$92 million in the quarter, if we exclude the non-recurring impact already mentioned, the year-on-year EBITDA growth was 35%, due to increased operations and the rationalization and dilution of costs and expenses. The EBITDA margin in the quarter was 59%. Despite the impacts of the pandemic, the outlook is for monitoring the capacity utilization level with a gradually recover in handling throughout the second half of the year.
In addition to initiatives to increase productivity indicated continued EBITDA growth year-over-year. Ultracargo remains focus on its capacity expansion by increasing its footprint in the Eletrobrás, where it already operate as well as expanding towards new regions, such as in Vila do Conde, state of Pará.
Moving on to Slide number 7, talking about Oxiteno, where total volume decreased by 9% and the volume of specialty chemicals goes down by 5% compared to the same quarter in 2019, due to a drop in coatings, automotive and oil and gas, despite the increase in the crop solutions and home and personal care segments. Oxiteno quarterly results benefited from better contribution margins in dollars per ton, driven by our richer sales mix, and by the effect of the devaluation of BRL against the U.S. dollar.
SG&A rose by 3% due to the FX translation effect of the overseas operations and increased expenses with international freight, following the increase in exports. Oxiteno remains committed to reducing costs and expenses, and we have already noticed in this quarter, a reduction in expenses with payroll, business travel and services in general, which contributed to preserve the results for the period. With this, Oxiteno’s EBITDA was R$162 million in the quarter, a growth of R$117 million compared to the second quarter of 2019, resulting from better unitary margins in U.S. dollar and the BRL devaluation despite lower sales volume.
Oxiteno’s outlook is to maintain the current volume levels for the most resilient segments such as Home & Personal Care and Crop Solutions and a gradual recovery in segments more impacted by the pandemic, notably Coatings. In addition, the positive effect of the exchange rate depreciation on external results, combined with the ramp-up at the Pasadena plant and better unitary margins, maintain the expectations for year-on-year growth in EBITDA.
Moving now to Slide number 8, talking about Ipiranga. Ipiranga saw an 18% year-on-year drop in sales volume with a decrease of 28% in auto cycle and 7% in diesel due to the significant impacts of the pandemic on fuel consumption in Brazil, mainly in April, followed by a gradual recovery in May and June. Total sales volume at Ipiranga in April declined by 27% on a year-on-year basis, while it fell by 17% in May and 7% in June.
We ended the second quarter with a network of 7,105 service stations across additional 94 and 95 churn in the period. The am/pm network ended the quarter with 2,345 stores of which 17 are company operated stores all located either in São Paulo or Rio de Janeiro. The outcome of the pandemic on the global economy, in addition to the price war in international markets, affected the supply and demand balancing the overall market, triggering sharp price volatility for gasoline and diesel. The prices for products failed dramatically late March and April followed by a partial recovery in May and June, besides the price of ethanol also fell by 25% in April.
Consequently, Ipiranga incurred significant inventory losses in the quarter due to the remaining effects of the price drop in March and also due to the additional prices reductions within the second quarter itself. However, Ipiranga posted SG&A reduction of 32% compared to the second quarter of 2019. This was a consequence of the initiatives deployed to cut the expenses of several fronts. Especially related to payroll and marketing as well as freight expenditures, the latter linked to a weaker sales volume. In addition, we kept our focus on optimizing working capital that contributed to a growth in operating cash generation compare to the second quarter of 2019.
With that, EBITDA was R$179 million, a reduction of 65% compared to the second quarter of 2019, mainly related to the lower sales volume and the impact from the price drop mentioned, which were partially offset by reducing the expenses. It is worth mentioning that the results for June represented an important evolution compare to the results for the rest of the quarter. The trend is for gradual recovering volumes and results, although still in level with the last year and also with lower volatility in fuel price. We saw – we observed this evolution in June, and we continue to see the same evolution in the beginning of the third quarter.
Talking now about Extrafarma, moving on to Slide number 9. Extrafarma ended the quarter with 410 stores practically stable compared to the first quarter of 2020. Of this unit, 38% are still in the ramp-up phase compared to 53% in the same quarter last year, reflecting greater selectivity in the expansion and the adoption of a more rigorous approach to underperforming stores. Gross revenue in the quarter was R$515 million, 8% down compared to the second quarter of 2019, mainly due to the 5% lower number of stores and the temporary closing of 7% of the stores located at shopping malls due to the pandemic. However, the stores that remain operations registered an increase of 4.6% in same-store sales, driven by the strengthening and expansion of home delivery operations, as well as two partnerships with delivery apps.
Gross profit reached R$141 million, a 7% fall on a year-over-year basis and corresponding to a gross margin of 27.5%. SG&A expenses fell by 15% in the quarter, thanks to a smaller number of stores and initiatives to improve productivity and optimize logistics, with emphasis on the reduction in payroll expenses and the opening up of distribution center in São Paulo in the third quarter of 2019.
With this, EBITDA was R$14 million in the quarter, excluding the non-recurring credits of R$60 million recorded in the second quarter of 2019. The EBITDA showed R$12 million improvement compared to the second quarter of 2019, due to the operational improvements made in previous quarters, and despite the impacts of the pandemic. Currently, all stores are operating and pharma sales remain resilient, despite the lower flow of customers, especially in drug stores located in shopping malls. We are continuing with our initiatives related to operational improvement, digital development, and cost reduction. And therefore the outlook is for continue EBITDA growth on a recurring basis.
Moving on to the consolidated results for Extrafarma on Slide number 10, net revenues were R$16 billion, 27% less than the second quarter of 2019, due to the impact of the pandemic. EBITDA was R$611 million in the quarter, a decline of 10% from the same period in 2019. If we exclude the non-recurring impacts that have already met that – we have already mentioned, maybe EBITDA was R$599 million, a decrease of 18% in the quarter, mainly due to the sharp decline EBITDA in Ipiranga, that was impacted by the social distance measures, offset by any increase in EBITDA from other businesses.
We posted net financial expenses of R$80 million in the second quarter compared to R$92 million in the same period of last year, a reduction of 13% largely due to the payment of the premium on the tender offer of notes in the second quarter of 2019, which increased interest expenses last year. This effect was partially offset by the appreciation Ultrapar stock price over the subscription warrants issued at the time of the acquisition of Extrafarma, and that had a negative impact in the second quarter of 2020.
Net income was R$50 million, 59% less than the second quarter of 2019, mainly the result of lower EBITDA. In this quarter, management opted for not paying out the interim dividends for the current year in order to preserve the company’s cash. As it stated in our bylaws, the minimum mandatory dividends will be paid out after the disclosure of the full year’s results.
CapEx was R$351 million, an increase of 7% compared to the second quarter of 2019, largely due to higher investments at Ipiranga, maintaining the service station network and Ultragaz for replacing and acquiring gas bottles. In our April, we announced a reduction of up to 30% in our investment plan for 2020. And in the second quarter, we implemented a greater control over investments as a measure to preserve cash. The optimization of working capital contributed to an operational cash generation of R$1.8 billion. If we discount net cash use investment activities, excluding financial investment, cash generation was R$1.4 billion, an increase of 33% over the first half of 2019.
Moving on to Slide number 11 and let’s talk about our debt profile. We ended the quarter with a leverage ratio of 3.2 times measured by net debt to adjusted EBITDA for the last 12 months, these lightly direction, compared to the 3.3 times for the first quarter of this year, this was only possible thanks to the strong cash generation in the quarter, which more than offset the sharp drop in EBITDA. It is worth mentioning that as from the first quarter of 2020, with the implementation of IFRS16, we began to include lease payable in our calculations of net debt, which contributed to an increasing leverage, despite these leases, as you know, not being classified as bank debts.
We ended the quarter with a cash position of R$8.4 billion boosted by the cash generation needed and by new funding. In July, we announced the issuances of $350 million in notes with a coupon and a note of 5.25% per year to the reopening of the notes mature in 2029. The proceeds will be used for being down that with shorter maturities and for mentioning with that profile.
With this, I conclude my presentation and we can now move to the Q&A sessions. Thank you.
Thank you. [Operator Instructions] Our first question comes from Frank McGann with BOA. Please go ahead.
Thank you very much. Two questions if I may. One, you mentioned that you have seen some pick up most noteably in June it seems post the sharper reductions in activity earlier in the second quarter. I was just wondering, if you could just provide a little more information for the various segments as to how you actually saw July and August perform so far year-over-year or versus the prior quarter. And secondly, just in terms of the potential for refining investment, I was just wondering what your current thoughts are now on how you’re seeing it, what type of participation you would have in any investment there and how you would see financing that?
Okay. Frank, thanks for the questions. Yes. We’ve seen from the end of the second quarter and also beginning of the third quarter a recovery in terms of volumes that were – let’s say very, very clear to note every time that we see more flexibilization in terms of the social business measures. Just to give an idea, right, if we were let’s say in the end of the second quarter, we were seeing levels of consolidated volumes decline compared to let’s say a year ago, around 14%, today these levels are below 10%. They’re likely 8% less. So if you take the last week of June, for example – sorry, the last week of July as an example the levels of decline, in other cycle around 10%. And remember that doing the second quarter, they were closer to 20%. Diesel is already up around 2% up compared to the same week a year ago. And the total volume is around 8% below a year ago if we take the last week of July. So this is an indication that there is a consistent recovery in terms of volumes, and there is a strong correlation between those volumes and every time that we see people somewhat going back to a more normal life and moving around more frequently. So there’s a very clear correlation.
As for refining and the participation, I mean, this basically – looking at, let’s say, what we see as a positive outcome of Petrobras selling 50% of its refining capacity. We believe that this is going to be positive for the market in general terms. There will be, in our point of view, benefits, not only for the fuel distribution companies but also for the final consumer in the end, right? I mean, the players with more scale, be able to negotiate long-term contracts, volume discounts. But this is going to take some time until it starts to, let’s say, impact the market because the process is ongoing. It’s going to take some time for it to be included.
Specifically about ourselves and since the process is ongoing, we cannot comment specifically on the situation on our end. But I mean, conceptually, in general terms, we see this move of Petrobras privatizing 50% of its refining capacity has been something very positive for the market.
Okay. Thank you very much.
Showing no further question. This concludes our question-and-answer session. At this time, I would like to turn the floor back to Mr. Pires for any closing remarks.
Well, thank you very much. Thanks everybody for the interest. And I hope to see you all again when we release our third quarter results. Thank you and have a good day. Bye-bye.
Thank you. This concludes today’s Ultrapar Q2 ‘20 results conference call. You may disconnect your lines at this time.